Condition: Liver Cirrhosis · Decompensated Cirrhosis of Liver · Acute on Chronic Liver Failure (ACLF) · Sponsor: European Foundation for Study of Chronic Liver Failure
The goal of this clinical trial is to determine primarily whether a combinatorial therapy based on the administration of human albumin and enoxaparin is safe and effective in patients with decompensated cirrhosis discharged from the hospital. The main questions it aims to answer are: * Is this combinatorial therapy safe and tolerable? * Is this combinatorial therapy effective? * does this combinatorial therapy cost more or less than standard medical therapy? Participants will attend to study visits in which several test will be performed to asses disease evolution while they are taking study medication. Researchers will compare experimental group treated with combinatorial therapy plus standard treatment with control group treated with standard treatment to see if there are differences in the responses to the questions raised above.
This description comes directly from the study's public registry record.
Anna Bosch · +34 93 227 14 03 · anna.bosch@efclif.com
Always discuss trial participation with your own doctor first.
| Hôpital Beaujon | Clichy, France | Recruiting |
| Universitätsklinikum Aachen AöR | Aachen, Germany | Recruiting |
| Universität Münster | Münster, Germany | Recruiting |
| IRCSS Azienda Ospedaliero Universitaria di Bologna Policlinico di Sant'Orsola | Bologna, Emilia-Romagna, Italy | Recruiting |
| Azienda Ospedaliero-Universitaria "Città della Salute e della Scienza di Torino" | Turin, Piedmont, Italy | Recruiting |
| Hospital Universitari Vall d'Hebron-VHIR | Barcelona, Barcelona, Spain | Recruiting |
| Hospital Universitario Ramón y Cajal | Madrid, Madrid, Spain | Recruiting |
| Hospital Clínic de Barcelona-FCRB | Barcelona, Spain | Recruiting |
| Royal Free Hospital | London, United Kingdom | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05895136